Vascular Graft Solutions

Company Overview

Snapshot

Founded in December 2008 by Eyal Orion, Vascular Graft Solutions operates with 11–50 employees. The company has raised $4.8 million across 6 funding rounds from 5 investors. In January 2020, Vascular Graft Solutions acquired the intellectual property developed by Kipsbay Medical Inc., enhancing its portfolio in surgical revascularization technologies.

Business overview

Vascular Graft Solutions (VGS) develops advanced technologies aimed at improving surgical revascularization, vascular reconstruction procedures, and arteriovenous fistulas. The company's core products include VEST, an external support for vein grafts used in coronary artery bypass surgery, and FRAME, an external support for vein grafts in peripheral revascularization and reconstruction. These devices are designed to address factors contributing to saphenous vein graft disease, such as disturbed flow patterns, high wall tension, and intimal hyperplasia. VGS serves the medical devices and healthcare provider markets within the Health Tech & Life Sciences sector, with products commercialized in international markets and undergoing clinical trials in North America.

Strategic signal

In January 2020, Vascular Graft Solutions acquired the intellectual property developed by Kipsbay Medical Inc. This strategic acquisition signals VGS's commitment to expanding its technological capabilities and product pipeline in the surgical revascularization space, potentially accelerating its market penetration and competitive advantage in developing solutions for vascular diseases.

Company Intelligence Q&A

What is Vascular Graft Solutions' primary focus?

Vascular Graft Solutions focuses on developing technologies to improve surgical revascularization, vascular reconstruction procedures, and arteriovenous fistulas, aiming to address underlying factors leading to saphenous vein graft disease.

When did Vascular Graft Solutions acquire intellectual property from Kipsbay Medical Inc.?

In January 2020, Vascular Graft Solutions acquired the intellectual property developed by Kipsbay Medical Inc.

What is the VEST technology?

VEST is an external support device developed by Vascular Graft Solutions for vein grafts used in coronary artery bypass surgery, designed to improve graft patency.

When did VEST receive CE mark approval?

VEST received CE mark approval in 2014 and is commercialized in international markets.

When did FRAME FR receive CE Mark approval?

In August 2019, Vascular Graft Solutions announced CE Mark approval for FRAME FR, an external support for AV fistula repair.